Show
Sort by
-
- Journal Article
- A1
- open access
Reduced protection of RIPK3-deficient mice against influenza by matrix protein 2 ectodomain targeted active and passive vaccination strategies
-
- Journal Article
- A1
- open access
In vivo therapy with M2e-specific IgG selects for an influenza A virus mutant with delayed matrix protein 2 expression
-
- Journal Article
- A1
- open access
Ring finger protein 213 assembles into a sensor for ISGylated proteins with antimicrobial activity
-
- Journal Article
- A1
- open access
Viral dosing of influenza A infection reveals involvement of RIPK3 and FADD, but not MLKL
-
- Journal Article
- A1
- open access
Specific targeting of IL-1β activity to CD8+ T cells allows for safe use as a vaccine adjuvant
-
Selected IL-1 activity on CD8+ T cells allows for safe enhancement of cellular immune responses
-
- Journal Article
- A1
- open access
Reverse engineering synthetic antiviral amyloids
-
- Journal Article
- A1
- open access
mRNA encoding a bispecific single domain antibody construct protects against influenza A virus infection in mice
-
- Journal Article
- A1
- open access
Recombinant viruses delivering the necroptosis mediator MLKL induce a potent antitumor immunity in mice
-
- Journal Article
- A1
- open access
Intracellular delivery of mRNA in adherent and suspension cells by vapor nanobubble photoporation
-
- Journal Article
- A1
- open access
The opposing effect of type I IFN on the T cell response by non-modified mRNA-lipoplex vaccines Is determined by the route of administration
-
Walter Fiers (1931-2019) : obituary
-
- Journal Article
- A1
- open access
Intranodal administration of mRNA encoding nucleoprotein provides cross-strain immunity against influenza in mice
-
- Journal Article
- A1
- open access
TIV vaccination modulates host responses to influenza virus infection that correlate with protection against bacterial superinfection
-
- Journal Article
- A1
- open access
Delivery of mixed-lineage kinase domain-like protein by vapor nanobubble photoporation induces necroptotic-like cell death in tumor cells
-
Towards the use of interleukin-1β as vaccine adjuvant
-
A two-amino acid mutation in murine IgA enables downstream processing and purification on staphylococcal superantigen-like protein 7.
-
- Journal Article
- A1
- open access
Super-resolution microscopy reveals significant impact of M2e-specific monoclonal antibodies on influenza A virus filament formation at the host cell surface
-
Vaccination with influenza hemagglutinin-loaded ceramic nanoporous microneedle arrays induces protective immune responses
-
- Journal Article
- A1
- open access
The role of matrix protein 2 ectodomain in the development of universal influenza vaccines
-
- Journal Article
- A1
- open access
Selective engagement of FcγRIV by a M2e-specific single domain antibody construct protects against influenza A virus infection
-
- Journal Article
- A1
- open access
Respiratory syncytial virus nonstructural proteins 1 and 2 : exceptional disrupters of innate immune responses
-
M2e-tetramer-specific memory CD4 T cells are broadly protective against influenza infection
-
- Journal Article
- A1
- open access
Surfactant protein B (SP-B) enhances the cellular siRNA delivery of proteolipid coated nanogels for inhalation therapy
-
Potent anti-viral vaccine adjuvant based on pH-degradable nanogels with covalently linked small molecule imidazoquinoline TLR7/8 agonist
-
- Journal Article
- A1
- open access
Species specificity of type III interferon activity and development of a sensitive luciferase-based bioassay for quantitation of mouse interferon-λ
-
Vaccine options for influenza : thinking small
-
- Journal Article
- A1
- open access
A respiratory syncytial virus vaccine based on the small hydrophobic protein ectodomain presented with a novel lipid-based formulation is highly immunogenic and safe in adults : a first-in-humans study
-
Transiently thermoresponsive acetal polymers for safe and effective administration of Amphotericin B as a vaccine adjuvant
-
- Journal Article
- A1
- open access
Porous nanoparticles with self-adjuvanting M2e-fusion protein and recombinant hemagglutinin provide strong and broadly protective immunity against influenza virus infections
-
Passively transferred M2e-specific monoclonal antibody reduces influenza A virus transmission in mice
-
- Journal Article
- A1
- open access
Removal of the N-glycosylation sequon at position N116 located in p27 of the respiratory syncytial virus fusion protein elicits enhanced antibody responses after DNA immunization
-
- Journal Article
- A1
- open access
Neutralization of Junín virus by single domain antibodies targeted against the nucleoprotein
-
- Journal Article
- A2
- open access
Single-domain antibodies and their formatting to combat viral infections
-
- Journal Article
- A1
- open access
Treatment with mRNA coding for the necroptosis mediator MLKL induces antitumor immunity directed against neo-epitopes
-
Clinical potential of prefusion RSV F-specific antibodies
-
- Journal Article
- A2
- open access
Therapeutic anti-tumor immunity directed against neo-epitopes by intratumor delivery of mRNA encoding MLKL
-
Bispecific T cell engaging antibody constructs targeting a universally conserved part of the viral M2 ectodomain cure and prevent influenza A virus infection
-
- Journal Article
- A1
- open access
A reassortant H9N2 influenza virus containing 2009 pandemic H1N1 internal-protein genes acquired enhanced pig-to-pig transmission after serial passages in swine
-
- Journal Article
- A1
- open access
Inflammatory monocytes regulate Th1 oriented immunity to CpG adjuvanted protein vaccines through production of IL-12
-
Oral delivery of Escherichia coli persistently infected with M2e-displaying bacteriophages partially protects against influenza A virus
-
Bronchoalveolar lavage of murine lungs to analyze inflammatory cell infiltration
-
- Journal Article
- A1
- open access
Effect of serial pig passages on the adaptation of an avian H9N2 influenza virus to swine
-
Hierarchical and redundant roles of activating FcγRs in protection against influenza disease by M2e-specific IgG1 and IgG2a antibodies
-
- Miscellaneous
- open access
IgG3 snitcher of RSV infections in the very young
-
Chemical-controlled activation of antiviral myxovirus resistance protein 1
-
- Journal Article
- A1
- open access
Potent single-domain antibodies that arrest respiratory syncytial virus fusion protein in its prefusion state
-
M2-based influenza vaccines : recent advances and clinical potential
-
Influenza-binding sialylated polymer coated gold nanoparticles prepared via RAFT polymerization and reductive amination
-
Optineurin deficiency in mice is associated with increased sensitivity to Salmonella but does not affect proinflammatory NF-κB signaling
-
Production and purification of recombinant filamentous bacteriophages displaying immunogenic heterologous epitopes
-
Increased protein degradation improves influenza virus nucleoprotein-specific CD8⁺ T cell activation in vitro but not in C57BL/6 mice
-
- Journal Article
- A1
- open access
Influenza and memory T cells : how to awake the force
-
- Miscellaneous
- open access
One against all : a broadly influenza neutralizing man-made monoclonal antibody passes phase I
-
Regulation of kynurenine biosynthesis during influenza virus infection
-
Crystal structure of the conserved amino terminus of the extracellular domain of matrix protein 2 of influenza A virus gripped by an antibody
-
GM-CSF treatment prevents respiratory syncytial virus– induced pulmonary exacerbation responses in postallergic mice by stimulating alveolar macrophage maturation
-
Phosphoproteomics to characterize host response during influenza A virus infection of human macrophages
-
- Journal Article
- A1
- open access
Illumina MiSeq sequencing disfavours a sequence motif in the GFP reporter gene
-
- Journal Article
- A1
- open access
A20 deficiency in lung epithelial cells protects against influenza A virus infection
-
- Journal Article
- A1
- open access
Immuno-modulating properties of saliphenylhalamide, SNS-032, obatoclax, and gemcitabine
-
Type I interferons interfere with the capacity of mRNA lipoplex vaccines to elicit cytolytic T cell responses
-
Structure of the extracellular domain of matrix protein 2 of influenza A virus in complex with a protective monoclonal antibody
-
- Journal Article
- A1
- open access
A GFP expressing influenza A virus to report in vivo tropism and protection by a matrix protein 2 ectodomain-specific monoclonal antibody
-
Functional comparison of Mx1 from two different mouse species reveals the involvement of loop L4 in the antiviral activity against influenza A viruses
-
- Journal Article
- A2
- open access
M2e-based universal influenza A vaccines
-
Scop3D : three-dimensional visualization of sequence conservation
-
- Journal Article
- A1
- open access
Developing 3D SEM in a broad biological context
-
- Journal Article
- A1
- open access
Protection against influenza A virus challenge with M2e-displaying filamentous Escherichia coli phages
-
Co-immunoprecipitation of the mouse Mx1 protein with the influenza A virus nucleoprotein
-
The C terminus of NS1 protein of influenza A/WSN/1933(H1N1) virus modulates antiviral responses in infected human macrophages and mice
-
Small hydrophobic protein of respiratory syncytial virus as a novel vaccine antigen
-
- Journal Article
- A1
- open access
Analysis of the genetic diversity of influenza A viruses using next-generation DNA sequencing
-
Influenza vaccines to control influenza-associated bacterial infection: where do we stand?
-
Sequence-dependent internalization of aggregating peptides
-
Comparison of the antiviral activity of Mus spretus Mx1 and Mus musculus A2G Mx1 against influenza A viruses
-
Single-domain antibodies targeting neuraminidase protect against an H5N1 influenza virus challenge
-
Akt inhibitor MK2206 prevents influenza pH1N1 virus infection in vitro
-
Presenting heterologous epitopes with hepatitis B core-based virus-like particles
-
- Journal Article
- A1
- open access
Protection and mechanism of action of a novel human respiratory syncytial virus vaccine candidate based on the extracellular domain of small hydrophobic protein
-
CD8⁺ T cell immunity against human respiratory syncytial virus
-
- Journal Article
- A1
- open access
Insight into highly conserved H1 subtype-specific epitopes in influenza virus hemagglutinin
-
Metabolic profiling of insect cell lines: unveiling cell line determinants behind system's productivity
-
- Journal Article
- A1
- open access
M2e-displaying virus-like particles with associated RNA promote T helper 1 type adaptive immunity against influenza A
-
- Journal Article
- A1
- open access
Immunogenicity of live attenuated B. pertussis BPZE1 producing the universal influenza vaccine candidate M2e
-
Natural and long-lasting cellular immune responses against influenza in the M2e-immune host
-
Hepatitis B core-based virus-like particles to present heterologous epitopes
-
Recombinant influenza virus carrying the respiratory syncytial virus (RSV) F85-93 CTL epitope reduces RSV replication in mice
-
Insight into structural diversity of influenza virus haemagglutinin
-
Anticancer compound ABT-263 accelerates apoptosis in virus-infected cells and imbalances cytokine production and lowers survival rates of infected mice
-
Challenges and advances towards the rational design of mRNA vaccines
-
Mx proteins: antiviral gatekeepers that restrain the uninvited
-
The Sin3a repressor complex regulates the balance between the activities of different STAT proteins
-
Tailor-made cleavage site attenuates influenza B
-
- Journal Article
- A1
- open access
A20 (Tnfaip3) deficiency in myeloid cells protects against influenza A virus infection
-
Influenza vaccines: T-cell responses deserve more attention
-
Polymeric multilayer capsule-mediated vaccination induces protective immunity against cancer and viral infection
-
The Sin3a repressor complex is a master regulator of STAT transcriptional activity
(2012) PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA. 109(30). p.12058-12063 -
- Journal Article
- A1
- open access
Immunization with M2e-displaying T7 bacteriophage nanoparticles protects against Influenza A virus challenge
-
Obatoclax, saliphenylhalamide, and gemcitabine inhibit influenza A virus infection